The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

被引:36
|
作者
Zhang, Ye [1 ]
Yan, Wen-Ting [1 ]
Yang, Ze-Yu [2 ]
Li, Yan-Ling [1 ]
Tan, Xuan-Ni [1 ]
Jiang, Jun [1 ]
Zhang, Yi [1 ]
Qi, Xiao-Wei [1 ]
机构
[1] Army Med Univ, Southwest Hosp, Breast & Thyroid Surg, Gaotanyan St 29, Chongqing 400038, Peoples R China
[2] Univ Chinese Acad Sci, Chongqing Gen Hosp, Breast & Thyroid Surg, Chongqing 400013, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
WT1; breast neoplasms; prognosis; carcinogenesis; TUMOR SUPPRESSOR GENE; ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL REGULATION; WILMS-TUMOR-1; PROTEIN; DOWN-REGULATION; POOR-PROGNOSIS; EXPRESSION; ISOFORMS; GROWTH; PROLIFERATION;
D O I
10.7150/ijbs.39958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Wilms' tumor gene 1 (WT1) was first cloned and identified as a tumor suppressor gene in nephroblastoma, subsequent studies have demonstrated that it can also play an oncogenic role in leukemia and various solid tumors. WT1 exerts biological functions with high tissue- and cell-specificity. This article reviews the relationship between WT1 and breast cancer from two aspects: (1) clinical application of WT1, including the relationship between expression of WT1 and prognosis of breast cancer patients, and its effectiveness as a target for comprehensive therapy of breast cancer; (2) the biological effects and molecular mechanisms of WT1 in the development and progression of breast cancer, including proliferation, apoptosis, invasion, and metastasis of breast cancer cells.
引用
收藏
页码:1474 / 1480
页数:7
相关论文
共 50 条
  • [31] Correlation of Wilms'Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer
    Pishbin, Fariba
    Ziamajidi, Nasrin
    Abbasalipourkabir, Roghayeh
    Najafi, Rezvan
    Farhadian, Maryam
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2023, 38 (03) : 338 - 350
  • [32] Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
    Silberstein, GB
    VanHorn, K
    Strickland, P
    Roberts, CT
    Daniel, CW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 8132 - 8137
  • [33] Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
    Silberstein, G. B.
    Van Horn, K.
    Strickland, P.
    Roberts, C. T.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (15):
  • [34] MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1
    Xie, FeiYan
    Hosany, Sumayyah
    Zhong, Shen
    Jiang, Yang
    Zhang, Fen
    Lin, LiLi
    Wang, XiaoBo
    Gao, ShenMeng
    Hui, XiaoQu
    PLOS ONE, 2017, 12 (10):
  • [35] Molecular profiling of breast cancer: clinical implications
    S Cleator
    A Ashworth
    British Journal of Cancer, 2004, 90 (6) : 1120 - 1124
  • [36] Soluble ICAM-1 in breast cancer:: clinical significance and biological implications
    Köstler, WJ
    Tomek, S
    Brodowicz, T
    Budinsky, AC
    Flamm, M
    Hejna, M
    Krainer, M
    Wiltschke, C
    Zielinski, CC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (09) : 483 - 490
  • [37] Soluble ICAM-1 in breast cancer: Clinical significance and biological implications
    Köstler W.J.
    Tomek S.
    Brodowicz T.
    Budinsky A.C.
    Flamm M.
    Hejna M.
    Krainer M.
    Wiltschke C.
    Zielinski C.C.
    Cancer Immunology, Immunotherapy, 2001, 50 (9) : 483 - 490
  • [38] Breast cancer stem cells: Biological and clinical implications
    Dontu, Gabriela
    Ginestier, Christophe
    Jauffret, Emma
    Wicha, Max
    TUMOR BIOLOGY, 2007, 28 : 54 - 54
  • [39] Investigating the role of WT1 in Brugada syndrome pathophysiology
    Marsman, E. M. J.
    Bosada, F. M.
    Offerhaus, J. A.
    Beekman, L.
    Wilde, L. M.
    Casini, S.
    Verkerk, A. O.
    Wilde, A. A. M.
    Boukens, B. J.
    Remme, C. A.
    Bezzina, C. R.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Role of the WT1 tumor suppressor in murine hematopoiesis
    Alberta, JA
    Springett, GM
    Rayburn, H
    Natoli, TA
    Loring, J
    Kreidberg, JA
    Housman, D
    BLOOD, 2003, 101 (07) : 2570 - 2574